J.P. Morgan Maintains Overweight Rating On CME Group

According to J.P. Morgan, CME Group CME reported good 2Q11 results with EPS of $4.38. J.P. Morgan said that the results included a net disposition gain after expenses of $6.6 million, but it feels that it was offset by unusually low investment income. “We see 2H11 as the transition to better volumes, increased revenue from recent investments, a greater buyback and lower expenses.” CME Group closed yesterday at $283.83.